Sort
30,917 grants matching “tumor microenvironment”
Regulation of the Tumor Microenvironment in Hepatocellular Carcinoma
$307,594Lewis R Roberts · Mayo Clinic Rochester · R01 · FY2013 · CA
Project 2: Heparan Sulfate Proteoglycans in Prostate Cancer Bone Metastasis
$307,584Mary C Farach-Carson · Cedars-Sinai Medical Center · P01 · FY2018 · CA
Novel Strategies for Hematopoietic Transplantation for Chronic Myeloid Leukemia
$307,583Richard E. Champlin · University Of Tx Md Anderson Can Ctr · P01 · FY2011 · CA
Redox-Control of MMP-1 and Senescence
$307,549Juan Andres Melendez · Albany Medical College · R01 · FY2011 · AG
The Role of Mechanotransduction in Progression of Tumor-induced Bone Disease
$307,542Scott A Guelcher · Vanderbilt University · R01 · FY2012 · CA
hiPS cells derived skeletal muscle progenitors and their extracellular vesicles for treatment of sarcopenia
$307,500Wanling Xuan · University Of South Florida · R01 · FY2024 · AG
Mapping a clinically significant internalizing tumor epitope space
$307,484Bin Liu · University Of California, San Francisco · R01 · FY2012 · CA
Mapping a clinically significant internalizing tumor epitope space
$307,484Bin Liu · University Of California, San Francisco · R01 · FY2011 · CA
Pathway, Network and Spatiotemporal Integration of Cancer Genomics Data
$307,434Benjamin Raphael · Princeton University · U24 · FY2025 · CA
Discovery and Validation of Tumor Immunoevasion Mechanisms
$307,402David Andrew Largaespada · University Of Minnesota · R01 · FY2012 · CA
Discovery and Validation of Tumor Immunoevasion Mechanisms
$307,402John R Ohlfest · University Of Minnesota · R01 · FY2011 · CA
Project-2:Defining the role of compartmentalized neuro-lymphatic networks on CRC and metastatic progression
$307,398Daniel S Mucida · Rockefeller University · U54 · FY2024 · CA
Mechanisms & Therapeutic Targeting of the Microenvironment in Pancreatic Cancer
$307,397Douglas Hanahan · Dana-Farber Cancer Inst · P01 · FY2010 · CA
(PQA1) Novel epigenetic mechanism mediate metformin inhibition of prostate cancer
$307,375Xin Li · New York University · R01 · FY2016 · CA
Project 2: Measuring and modeling the tumor and immune microenvironment before and during therapy and at the time of drug resistance
$307,307Arlene H Sharpe · Harvard Medical School · U54 · FY2021 · CA
Controllable In Vivo Genome Editing for Immune-Checkpoint Blockade in Solid Tumors
$307,164Sheng Tong · University Of Kentucky · R01 · FY2019 · EB
Tak1, a novel prostate cancer tumor suppressor
$307,100Scott D Cramer · Wake Forest University Health Sciences · R01 · FY2010 · CA
Tak1, a novel prostate cancer tumor suppressor
$307,100Scott D Cramer · Wake Forest University Health Sciences · R01 · FY2009 · CA
Prx1 in malignant progression of prostate cancer
$307,083Candace S Johnson · Roswell Park Cancer Institute Corp · R01 · FY2008 · CA
Biomedical Studies and Cellular Imaging via Atomic Force Microscopy
$307,075Albert J Jin · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2015 · EB
Tak1, a novel prostate cancer tumor suppressor
$307,069Scott D Cramer · University Of Colorado Denver · R01 · FY2012 · CA
Training of Surgeon Scientists in Basic and Translational Cancer Research
$307,014John McAuliffe · Albert Einstein College Of Medicine · T32 · FY2023 · CA
hiPS cells derived skeletal muscle progenitors and their extracellular vesicles for treatment of sarcopenia
$306,988Wanling Xuan · University Of South Florida · R01 · FY2023 · AG
Investigation of the role of UNC-45A in Paclitaxel-mediated microtubule stability
$306,965Martina Bazzaro · University Of Minnesota · R01 · FY2020 · GM
Investigation of the role of UNC-45A in Paclitaxel-mediated microtubule stability
$306,965Martina Bazzaro · University Of Minnesota · R01 · FY2019 · GM